BLOOMBERG Lunch Money February 18, 2014
Only two things people were doing this weekend, benj watching house of cards or making deals. A big one in pharma. Forest lives being bought by actavis 425 billion. A big winner for carl icahn, number two shareholder at forest labs. Persistence pays off for carl icahn, he has threatened a proxy fight for the last three years on this company. To appease him, the company gave him seats on the board and he got his guy as ceo, as a result you get the outcome carl icahn onwanted. That is not the only...
Source: archive.org